First Commercial Sales: Humacyte commenced its commercial launch of Symvess in late February 2025 after the first commercial batch was released by the FDA. The first commercial shipments containing ...

While the virus has the potential to infect humans, no real-world cases have been identified, and it does not enter human ...

NewBiologix, a next-generation biotechnology company pioneering the future of recombinant adeno-associated virus (rAAV) production through a unique DNA-based platform built on stable cell line ...

An executive order signed on May 5, 2025, weaponizes the false claim that the virus that causes COVID-19 was manufactured in ...

County public health officials are asking anyone who may have come into contact with a rabid bat at the Safari Park to ...